Large-scale testing (Phase 3)Study completedNCT05109234
What this trial is testing
Test the Long-term Safety, Tolerability and Efficacy of Brivaracetam in Study Participants 2 to 26 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy
Who this might be right for
Childhood Absence EpilepsyJuvenile Absence Epilepsy
UCB Biopharma SRL 84